Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-04-06 ROBINS CHAD M CEO and Chairman Sale −2,200 $42.48 $93K 1,759,661
2021-04-06 ROBINS CHAD M CEO and Chairman Sale −1,200 $43.08 $52K 1,758,461
2021-03-31 Taylor Stacy L SVP and General Counsel Option exercise +1,042 $7.80 $8K 16,078
2021-03-31 Taylor Stacy L SVP and General Counsel Option exercise +1,771 $6.55 $12K 17,849
2021-03-31 Taylor Stacy L SVP and General Counsel Option exercise +1,354 $31.71 $43K 19,203
2021-03-31 Taylor Stacy L SVP and General Counsel Sale −4,167 $40.00 $167K 15,036
2021-03-31 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,042 26,042
2021-03-31 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,771 21,250
2021-03-31 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,354 47,396
2021-03-25 ROBINS HARLAN S Chief Scientific Officer Option exercise +5,290 $6.32 $33K 74,650
2021-03-25 ROBINS HARLAN S Chief Scientific Officer Sale −3,809 $38.13 $145K 70,841
2021-03-25 ROBINS HARLAN S Chief Scientific Officer Sale −1,481 $38.72 $57K 69,360
2021-03-25 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −5,290 167,485
2021-03-24 ROBINS HARLAN S Chief Scientific Officer Option exercise +6,395 $6.32 $40K 75,755
2021-03-24 ROBINS HARLAN S Chief Scientific Officer Sale −1,820 $39.43 $72K 73,935
2021-03-24 ROBINS HARLAN S Chief Scientific Officer Sale −4,175 $40.33 $168K 69,760
2021-03-24 ROBINS HARLAN S Chief Scientific Officer Sale −400 $41.76 $17K 69,360
2021-03-24 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −6,395 172,775
2021-03-23 ROBINS HARLAN S Chief Scientific Officer Option exercise +7,790 $6.32 $49K 77,150
2021-03-23 ROBINS HARLAN S Chief Scientific Officer Sale −7,790 $41.93 $327K 69,360

Page 51 of 120 · 2,386 trades